Valiant Organics Limited · NSE:VALIANTORG
Valiant Organics — Q2 FY2026 Earnings Presentation
24 slides from Valiant Organics's earnings presentation, Nov 15, 2025
Slide 1: Investors' Presentation filing letter to BSE and NSE
November 15, 2025 To, To, Listing / Compliance Department Listing / Compliance Department BSE LTD National Stock Exchange of India Limited Phiroze Jeejeebhoy Towers Exchange Plaza, Plot No. C/1, Dalal Street G Block Bandra-Kurla Complex, Mumbai- 400 001 Bandra (E), Mumbai- 400 051. SCRIP CODE – 5401
Slide 2: Earnings Presentation Q2/H1-FY26
Ea r ni n gs P re s e nta ti o n | Q 2 /H1 - F Y 2 6
Slide 3: Snapshot
SNAPSHOT One of the largest chlorophenol One of the leading manufacturer of derivatives manufacturer globally Benzene derivatives products One of the largest domestic PNA One of the few commercial players in manufacturer Ortho Anisidine and Para Anisidine Diversified client base across Amongst 1st f
Slide 4: Company Overview
Company Overview Valiant Organics Limited was incorporated in 1984 by first generation technocrats and is headquartered out of Mumbai, India. The company is focused on the manufacturing and marketing of specialty chemicals which find usage in a variety of industries, including agrochemicals, pharmac
Slide 5: Chemistries and Product Basket
Chemistries And Product Basket H1-FY26 Revenue Share Hydrogenation Ammonolysis 50% Key Products: Industries Served: Key Products: • Ortho Anisidine Industries Served: • Dyes • Para Nitro Aniline • Para Anisidine • Dyes • Pigments • Ortho Chloro Para Nitro Aniline • IPPCA • Pigments • Pharmaceutical
Slide 6: Manufacturing Footprint
Manufacturing Footprint CHLORINATION – SARIGAM HYDROGENATION & METHOXYLATION- • Capacity: 18,000 MTPA JHAGADIA UNIT 1 • Products: PCP, OCP, 2,4 DCP, 2,6 DCP, • Capacity: 28,800 MTPA 2,4,6 TCP • Products: ONA/OA, PNA/PA, IPPCA, CONVERSION PRODUCTS AMMONOLYSIS - VAPI HYDROGENATION – JHAGADIA UNIT 2 •
Slide 7: Key Strengths
Key Strengths Domain expertise and broad Plant locations are process understanding in a Wide supply chain strategically located near variety of chemistries. The provides the continuous ports to provide a executive team is made up of availability of adequate competitive advantage, first-generation te
Slide 8: Q2/H1-FY26 Highlights
Q2/H1-FY26 HIGHLIGHTS Valiant Organics Limited | Q2-2026 7
Slide 9: Consolidated Financial Highlights
CONSOLIDATED FINANCIAL HIGHLIGHTS Q2-FY26 CONSOLIDATED FINANCIAL HIGHLIGHTS H1-FY26 CONSOLIDATED FINANCIAL HIGHLIGHTS INR 1,573 Mn INR 3,617 Mn Operational Revenue Operational Revenue INR 212Mn INR 459 Mn Operating EBITDA Operating EBITDA 13.48% 12.69% Operating EBITDA Margin Operating EBITDA Margin
Slide 10: Q2/H1-FY26 Operational Highlights
Q2/H1-FY26 Operational Highlights • Revenue remained stable sequentially and registered healthy year-on-year growth, Q2-FY26 Revenue Break-up – Chemistries supported by better realizations and steady demand conditions. Others, 6% • Gross Profit came in at INR 718 million, with gross margin improving
Slide 11: Key Chemistries: Revenues and Sales Volumes
Key Chemistries Chlorination (INR Mn) Hydrogenation (INR Mn) Ammonolysis (INR Mn) Others (INR Mn) 1,200 1,082 60 0 25 0 45 0 394 1,000 55 0 479 475 REVENUES 40 0 50 0 427 20 0 730 725 45 0 35 0 274 286 800 40 0 30 0 35 0 15 0 118 25 0 600 30 0 25 0 94 97 20 0 10 0 400 20 0 15 0 15 0 10 0 50 200 10 0
Slide 12: Quarterly Consolidated Financial Performance
Quarterly Consolidated Financial Performance Particulars (INR Mn) Q2-FY26 Q2-FY25 Y-o-Y Q1-FY26 Q-o-Q Revenue from Operations 1,573 1,602 (1.8)% 2,044 (23.0)% Total Expenses 1,361 1,578 (13.8)% 1,796 (24.2)% EBITDA 212 24 NA 248 (14.5)% EBITDA Margins (%) 13.48% 1.50% NA 12.13% 135 Bps Other Income
Slide 13: YTD Consolidated Financial Performance
YTD Consolidated Financial Performance Particulars (INR Mn) H1-FY26 H1-FY25 Y-o-Y Revenue from Operations 3,617 3,281 10.2% Total Expenses 3,158 3,099 1.9% EBITDA 459 182 NA EBITDA Margins (%) 12.69% 5.55% 714 Bps Other Income 13 29 (55.2)% Depreciation 192 176 9.1% Finance Cost 102 132 (22.7)% PBT
Slide 14: Quarterly Standalone Financial Performance
Quarterly Standalone Financial Performance Particulars (INR Mn) Q2-FY26 Q2-FY25 Y-o-Y Q1-FY26 Q-o-Q Revenue from Operations 1,572 1,602 (1.9)% 2,044 (23.1)% Total Expenses 1,360 1,579 (13.9)% 1,796 (24.3)% EBITDA 212 23 NA 248 (14.5)% EBITDA Margins (%) 13.49% 1.44% NA 12.13% 136 Bps Other Income 2
Slide 15: YTD Standalone Financial Performance
YTD Standalone Financial Performance Particulars (INR Mn) H1-FY26 H1-FY25 Y-o-Y Revenue from Operations 3,616 3,281 10.2% Total Expenses 3,157 3,099 1.9% EBITDA 459 182 NA EBITDA Margins (%) 12.69% 5.55% 714 Bps Other Income 13 24 (45.8)% Depreciation 192 176 9.1% Finance Cost 102 132 (22.7)% PBT (E
Slide 16: Historical Financial Overview
HISTORICAL FINANCIAL OVERVIEW Valiant Organics Limited | Q2-2026 15
Slide 17: Historical Consolidated Income Statement
Historical Consolidated Income Statement Particulars (INR Mn) FY23 FY24 FY25 H1-FY26 Revenue from Operations 10,518 7,231 7,188 3,617 Total Expenses 8,875 6,849 6,651 3,158 EBITDA 1,643 382 537 459 EBITDA Margins (%) 15.62% 5.28% 7.47% 12.69% Other Income 80 93 86 13 Depreciation 292 349 358 192 Fin
Slide 18: Historical Consolidated Balance Sheet
Historical Consolidated Balance Sheet Particulars (INR Mn) FY24 FY25 H1-FY26 Particulars (INR Mn) FY24 FY25 H1-FY26 EQUITY 7,293 7,253 7,395 Non-Current Assets 8,352 8,269 8,786 a) Equity Share Capital 276 280 280 a) Property, Plant and Equipment 6,297 6,437 6,940 b) Other Equity 7,017 6,973 7,115 c
Slide 19: Historical Standalone Income Statement
Historical Standalone Income Statement Particulars (INR Mn) FY23 FY24 FY25 H1-FY26 Revenue from Operations 9,116 6,772 7,188 3,616 Total Expenses 7,817 6,376 6,651 3,157 EBITDA 1,299 396 537 459 EBITDA Margins (%) 14.25% 5.85% 7.47% 12.69% Other Income 29 29 81 13 Depreciation 276 340 358 192 Financ
Slide 20: Historical Standalone Balance Sheet
Historical Standalone Balance Sheet Particulars (INR Mn) FY24 FY25 H1-FY26 Particulars (INR Mn) FY24 FY25 H1-FY26 EQUITY 6,649 6,616 6,752 Non-Current Assets 7,818 7,750 7,775 a) Equity Share Capital 276 280 280 a) Property, Plant and Equipment 6,297 6,437 6,940 b) Other Equity 6,373 6,336 6,472 b)
Slide 21: Consolidated Financial Highlights
Consolidated Financial Highlights Operational Revenue (INR Mn) EBITDA (INR Mn) & EBITDA Margins (%) PAT (INR Mn) & PAT Margins (%) 1,400 10,518 10,00 0 1,643 1,100 1,026 17 .0 0% 7,500 7,231 7,188 800 9.75% 12 .0 0% 3,617 5,000 15.62% 537 459 500 382 12.69% 7.00 % 2,500 7.47% 139 5.28% 200 3.84% - 2
Slide 22: Capital Market Information
Capital Market Information Share Price up to 30th September, 2025 30% 10% -10% -30% -50% -70% Oct-24 Nov-24 Dec-24 Jan-25 Feb-25 Mar-25 Apr-25 May-25 Jun-25 Jul-25 Aug-25 Sep-25 Valiant Organics Sensex Price Data (As of 30th September, 2025) INR Shareholding pattern (As of 30th September, 2025) Face
Slide 23: Disclaimer
Disclaimer Valiant Organics Limited No representation or warranty, express or implied, is made as to, and no reliance should be placed on, the fairness, accuracy , completeness or correctness of the information or opinions contained in this presentation. Such information and opinions are in all even
Slide 24: Thank You
THANK YOU Valiant Organics Limited | Q2-2026 23